BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19942040)

  • 1. Benign prostatic hyperplasia and lower urinary tract symptoms. Preface.
    Blaivas JG; Weiss JP
    Urol Clin North Am; 2009 Nov; 36(4):xi-xiii. PubMed ID: 19942040
    [No Abstract]   [Full Text] [Related]  

  • 2. Benign prostatic hyperplasia: treat or wait?
    Davidson JH; Chutka DS
    J Fam Pract; 2008 Jul; 57(7):454-63. PubMed ID: 18625168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiology, epidemiology, and natural history of benign prostatic hyperplasia.
    Bushman W
    Urol Clin North Am; 2009 Nov; 36(4):403-15, v. PubMed ID: 19942041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Hellstrom WJG, et al.: Ejaculatory dysfunction and its association with lower urinary tract symptoms of benign prostatic hyperplasia (BPH) and BPH treatment. (Urology 2009;74:15-21).
    Schmid HP; Böhlen D
    Urology; 2009 Dec; 74(6):1377; author reply 1377-8. PubMed ID: 19962542
    [No Abstract]   [Full Text] [Related]  

  • 5. Ejaculatory dysfunction and its association with lower urinary tract symptoms of benign prostatic hyperplasia and BPH treatment.
    Hellstrom WJ; Giuliano F; Rosen RC
    Urology; 2009 Jul; 74(1):15-21. PubMed ID: 19428091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Male lower urinary tract symptoms: the role of the prostate].
    Gratzke C; Stief CG
    MMW Fortschr Med; 2013 Aug; 155(14):34. PubMed ID: 24006592
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of invasive urodynamic testing in benign prostatic hyperplasia and male lower urinary tract symptoms.
    Mehdizadeh JL; Leach GE
    Urol Clin North Am; 2009 Nov; 36(4):431-41, v. PubMed ID: 19942043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Currently available treatment guidelines for men with lower urinary tract symptoms.
    Roehrborn CG
    BJU Int; 2008 Nov; 102 Suppl 2():18-23. PubMed ID: 19032606
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation and treatment of lower urinary tract symptoms in older men.
    Abrams P; Chapple C; Khoury S; Roehrborn C; de la Rosette J;
    J Urol; 2009 Apr; 181(4):1779-87. PubMed ID: 19233402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitating the medical management of benign prostatic hyperplasia in primary care.
    Rees J
    BJU Int; 2010 Jan; 105(1):131-2. PubMed ID: 20132105
    [No Abstract]   [Full Text] [Related]  

  • 11. Does sildenafil affect uroflowmetry values in men with lower urinary tract symptoms suggestive of benign prostatic enlargement?
    Güler C; Tüzel E; Doğantekin E; Kiziltepe G
    Urol Int; 2008; 80(2):181-5. PubMed ID: 18362490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    McVary KT; Roehrborn CG; Kaminetsky JC; Auerbach SM; Wachs B; Young JM; Esler A; Sides GD; Denes BS
    J Urol; 2007 Apr; 177(4):1401-7. PubMed ID: 17382741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial comment on: the relationship between objective frequency-volume chart data and the I-PSS in men with lower urinary tract symptoms.
    De Nunzio C
    Eur Urol; 2007 Sep; 52(3):818. PubMed ID: 17276582
    [No Abstract]   [Full Text] [Related]  

  • 14. Alcohol consumption is associated with a decreased risk of benign prostatic hyperplasia.
    Parsons JK; Im R
    J Urol; 2009 Oct; 182(4):1463-8. PubMed ID: 19683313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertise.
    Speakman M; Batista J; Berges R; Chartier-Kastler E; Conti G; Desgrandchamps F; Dreikorn K; Lowe F; O'Leary M; Perez M; Trachtenberg J; Tubaro A; Meesen B; Smets L; Stoevelaar H
    Prostate Cancer Prostatic Dis; 2005; 8(4):369-74. PubMed ID: 16130013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally invasive therapy of lower urinary tract symptoms.
    Donnell RF
    Urol Clin North Am; 2009 Nov; 36(4):497-509, vi-vii. PubMed ID: 19942048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual impact of treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Wiser HJ; Köhler TS
    Curr Urol Rep; 2010 Jul; 11(4):228-35. PubMed ID: 20467845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of benign prostate syndrome].
    Herlemann A; Strittmatter F; Stief CG; Gratzke C
    MMW Fortschr Med; 2013 Aug; 155(14):39-42. PubMed ID: 24006594
    [No Abstract]   [Full Text] [Related]  

  • 20. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.